Objectives We investigated the apoptotic activities of acrofolione A (1) and B (2) isolated from Acronychia pedunculata against a human pre-B cell leukaemia cell line (NALM-6) to explore the apoptosis-related signalling molecules targeted by 1 and 2. Methods The apoptosis effects of 1 and 2 in NALM-6 cells were investigated by TUNEL staining, annexin V, mitochondria membrane potential and caspase 3/7 activity. We carried out a protein array to explore the signalling molecules involved in apoptosis comprehensively. Key findings Acrofolione A (1) suppressed the growth of NALM-6, K562 and HPB-ALL cells (IC 50 16.7 AE 1.9, 17.9 AE 0.3 and 10.1 AE 0.2 lM, respectively) more effectively than acrofolione B (2). Both compounds time-dependently increased the number of NALM-6 cells with abnormal nuclei, and increased the number of annexin V-positive cells and decreased the mitochondrial membrane potential of NALM-6 cells. Acrofolione A (1) markedly elevated caspase 3/7 activity and increased the number of TUNEL-positive cells. Cells treated with either compound showed enhanced expression of cleaved PARP and cleaved caspase 3 and 7, and reduced survivin protein levels. Conclusions Acrofolione A (1) and B (2) may be useful in the treatment of various types of leukaemia.
Introduction
Acute lymphoblastic leukaemia (ALL) is a common cancer in children and the elderly and causes fever, anaemia and haemorrhagic diathesis. Relapsed elderly and adult patients with ALL have poor prognosis, with 5-year survival of around 7%. [1] Human precursor B cell acute lymphoblastic leukaemia (B-ALL) is now primarily treated by chemotherapy using various anticancer agents, including anthracycline and vincristine, which are effective but often induce adverse effects. Recently, monoclonal antibodies, such as rituximab, epratuzumab and linked cytotoxic agents, have been developed for B-ALL therapy. However, these agents have problems with safety and efficacy that must be overcome.
Many natural products are used in folk medicine and have provided numerous seed compounds that have been vital in drug discovery. There are many reports of the anticancer effects of plant extracts and compounds. We have reported that naphthoquinone dimers, xanthones and coumarins isolated from plants belonging to Plumbaginaceae, Rutaceae and Hypericeae families, respectively, induced cytotoxic effects and cell cycle arrest in cancer cell lines. [2] [3] [4] Components from plants may be useful in the development of novel anticancer drugs with fewer side effects.
Acronychia pedunculata (L.) Miq. (Rutaceae) is a small evergreen plant widely distributed from East Asia to South Asia, including South China, India, Sri Lanka and Indonesia. Extracts of the leaves, bark, stems and fruits of this plant are widely used in folk medicine to treat scabies, sores and ulcers, [5] and are reported to have antimicrobial activity, [6] cytotoxicity [7] [8] [9] [10] and antioxidant capacity. [11] Various compounds have been isolated and identified from A. pedunculata, including quinolone alkaloids [12] and phenolic compounds. [13, 14] We previously reported the new acetophenones acrophenone A, B and C and several known acetophenone dimer compounds, [15] such as acrovestenol and acrovestone. Previous reports [9, 11, [16] [17] [18] have indicated that the biological activities of acetophenone monomers are low. Our experiments have also shown that the acetophenone monomers prenylacronylin and acronylin, which are predicted to be components in acetophenone dimers, have cytotoxic effects. Kouloura et al. [10] reported that acrovestone has considerable cytotoxic effects on some cancer cell lines. Rottlerin, which contains an acetophenone moiety, also has antiproliferative activities against cancer cell lines. [19] These compounds bearing acetophenone moieties potently inhibit cancer cell growth, and thus may have anticancer activity.
Acrofolione A and B were isolated from A. trifoliata and subsequently also from A. pedunculata, and their structures were first elucidated by Oyama et al. [18] These compounds are unique acetophenone dimers containing a dihydrofuran moiety and have cytotoxic activity against human cancer cell lines. Acrofolione A (1) and B (2) appear to have different activities toward different cell lines, but both likely suppress cell growth or induce apoptosis in human leukaemia cells. These compounds are potent inhibitors of 5-lipoxygenase and microsomal prostaglandin E2 synthase-1, which cause inflammation. [7] However, there have been only a few reports showing the biological effects of acrofolione A (1) and B (2) , and the details of their cytotoxic effects remain unclear. In general, the cytotoxic effect arises from the disruption of various processes, such as cell cycle, cell metabolism and intracellular signalling, which is a marker of apoptosis and necrosis. Whether acrofolione A (1) and B (2) cause apoptosis or necrosis has been unknown.
This study aimed to clarify the apoptotic effects of acrofolione A (1) and B (2) and to explore the intracellular signalling molecules or pathways related to their activity in the human NALM-6 pre-B leukaemia cell line.
Materials and Methods

Plant materials
The plant materials used in this study, A. pedunculata (L.) Miq. (Rutaceae), were collected in Taipei Hsien, Taiwan, in April 1985 and were authenticated by Professor C. S. Kouh of the National Cheng-Kung University, Taiwan. A voucher specimen (NCKU Wu 1985000008) has been deposited in the herbarium of National Cheng Kung University, Tainan, Taiwan.
Extraction and isolation
Dried stems (1.2 kg) of A. pedunculata were extracted under reflux with MeOH (3 9 4 L), and the solvent was evaporated under reduced pressure to give the MeOH extract (65.1 g). The acetone-soluble portion (15.1 g) of the MeOH extract was subjected to silica gel column chromatography (100-200 mesh, 5.0 9 90 cm, 200 g) by eluting with benzene-acetone (10 : 1, 300 mL; 4 : 1, 300 mL; 3 : 1, 300 mL; 2 : 1, 300 mL; 1 : 1, 300 mL), acetone (300 mL), and MeOH (300 mL) successively to give 15 fractions. The flow rate was approximately 15 mL/min. Fraction 8 (697 mg, eluted with benzene-acetone (3 : 1)) was separated using silica gel flash column chromatography (150-320 mesh, 20 g, 2.0 9 45 cm) by eluting with benzene-acetone ((10 : 1), 600 mL) to give 11 fractions. Fraction 8-6 (201 mg) was purified by preparative normal phase thin layer chromatography using CHCl 3 -EtOAc (40 : 1) to afford compounds 1 (31 mg) and 2 (50 mg).
Cell culture and cell lines
B cell precursor leukaemia (NALM-6), erythroid leukaemia (K562) and T cell leukaemia (HPB-ALL) cells obtained from Tohoku University were grown in RPMI 1640 medium supplemented with 10% heat-inactive fetal calf serum, penicillin, streptomycin, nonessential amino acids, sodium pyruvate and HEPES under 5% CO 2 at 37°C.
Isolation of peripheral blood mononuclear cells
Peripheral blood samples from healthy volunteers were collected in heparinized test tubes. The samples were diluted at a 1 : 1 ratio with phosphate-buffered saline (PBS), layered onto Histopaque-1077 medium (Sigma-Aldrich Co., St Louis, MO, USA) at a volume ratio of 1 : 1, and centrifuged at 400g for 30 min. The peripheral blood mononuclear cell (PBMNC) layer was collected and washed twice with culture medium, and then the cells were suspended in fresh medium.
Cell proliferation assay
Each cell line (1 9 10 4 /well) and PBMNCs (1 9 10 5 /well) were seeded into 96-well plates and subcultured for 24 h. The cells were treated for 48 h with acrofolione A (1) or B (2) at the defined concentrations. Both compounds were dissolved in DMSO. DMSO at the maximum concentration of 0.5% did not affect cell viability. According to the manufacturer's instructions, MTS Reagent (CellTiter 96 AQueousOne Solution Cell Proliferation Assay; Promega, Madison, WI, USA) was added to each well after culture with either compound. Absorbance was recorded at 490 nm using a microplate reader (Molecular Devices, Sunnyvale, CA, USA). Cell viability (%) is expressed relative to that of the vehicle control. Each experiment was performed in quadruplicate. Staurosporine was used as a positive control. IC 50 values were calculated using Softmax Pro6 (Molecular Devices).
Cell morphological analysis
NALM-6 cells treated with 10 lM acrofolione A (1) or B (2) were collected at various time points, smeared and dried on glass slides, and then stained with haematoxylin for 3 min and rinsed with distilled water. The specimens (500 cells per sample) were categorized as having normal or abnormal nuclei by microscopic observation at 10009 magnification, and the % ratio of cells having normal nuclei was determined.
TUNEL assay
NALM-6 cells were seeded at 1 9 10 5 cells/well in 96-well dishes and subcultured for 24 h, and then cultured for 6 and 24 h with either 20 lM acrofolione A (1) or B (2). DNA fragmentation was analysed using an apoptosis in situ detection kit (Wako Pure Chemical Industries Ltd., Osaka, Japan) according to the manufacturer's instructions. Briefly, collected cells were fixed in 4% formalin neutral buffer and smears were prepared. The cells were incubated with DNA labelling solution for 15 min at 37°C and reacted with peroxidase-conjugated antibody for 30 min at 37°C after washing. Next, the cell smears were counterstained with 0.5% methylene green solution and viewed using an inverted microscope (Axiovert Lab.A1; Zeiss, Oberkochen, Germany). Five images were randomly selected with 100-200 cells per image and the number of TUNEL-positive cells stained brown was counted.
Annexin V/propidium iodide staining
We monitored apoptotic cells using annexin V-FITC/ propidium iodide staining with an MEBCYTO apoptosis detection kit (MBL Co., Aichi, Japan) in accordance with the manufacturer's instructions. NALM-6 cells (1 9 10 6 cells/well in six-well dishes) were treated with either 15 lM acrofolione A (1) or B (2) for 6, 12, 24 or 48 h. Then, the cells were stained with 5 lL of annexin-FITC and 5 lL of propidium iodide for 30 min at room temperature. Annexin V-FITC/propidium iodide-positive cells were monitored using a FACS Canto II flow cytometer (BD Bioscience, San Jose, CA, USA). Data were analysed using CellQuest software (BD Bioscience).
Appropriate controls were used to correct the FITC and PI channels. Gating on the cell population was set up using a FSC/SSC scatter plot and 10000 events were recorded and analysed for the annexin-V/propidium iodide stain assay. The total percentage of apoptotic cells was defined as the sum of the early and late stages of apoptosis (i.e. annexin V-FITC-positive) according to a previous study. [20] Mitochondrial membrane potential NALM-6 cells were seeded into 96-well plates at 1 9 10 5 cells per well. After the cells were incubated for 24 h, they were treated with 20 lM acrofolione A (1) or B (2) and cultured for 48 h. The mitochondrial membrane potential of the cells was measured using a membrane potential cytotoxicity kit (Mito-ID; Enzo Life Science International, Plymouth Meeting, PA, USA) according to the manufacturer's instructions. [4] Briefly, mitochondrial membrane potential solution was applied to each treated cell sample and incubated for 30 min at 37°C. After washing with HBSS buffer, the fluorescence intensity of the treated cells was measured at 490 nm excitation and 590 nm emission using the FACS Canto II flow cytometer. Untreated cells served as a reference control. These measurements were performed for five independent experiments.
Cell cycle analysis
NALM-6 cells were seeded at 1 9 10 5 cells/well in 96-well dishes and subcultured for 24 h, according to our previous report.
[ 21] The cells were then cultured for 24, 48 and 72 h with 15 lM acrofolione A (1) or B (2), and they were then fixed in 70% ethanol and treated with 0.5% ribonuclease for 30 min. DNA was stained with 4 0 ,6-diamidino-2-phenylindole (DAPI, 1.2 lM) for 30 min at room temperature in the dark. Cells treated with DAPI were measured with the FACS Canto II instrument using 405nm excitation and then were analysed using FlowJo analysis software (BD Biosciences) including the Watson model. Untreated cells were defined as the reference control. These measurements were performed independently in triplicate.
Caspase 3/7 activity NALM-6 cells were seeded into 96-well plates at a density of 1 9 10 5 cells per well. Cell lysates for caspase 3/7 activity determination were obtained 24 h after treatment with either 10 lM acrofolione A (1) or B (2) after subculturing. Caspase 3/7 activity was determined using a Caspase-Glo 3/ 7 assay kit (Promega) according to the manufacturer's protocol. In brief, the cells were treated with caspase-Glo 3/7 reagent (100 lL/well) for 2 h at room temperature, and the luminescence was measured using a microplate reader (Molecular Devices). Untreated cells served as the reference control. These measurements were performed independently four times.
Expression of phosphorylated tyrosine proteins
NALM-6 cells were seeded into 12-well plates at 1 9 10 6 cells per well. After incubation for 24 h, acrofolione A or B (15 lM) was added and the cells were incubated for 6, 12, 24 and 48 h. As described in our previous report, [22] the collected cells were immediately lysed in CelLytic-M reagent (Sigma-Aldrich) containing complete protease inhibitor cocktail (Roche Diagnostics Ltd., Basel, Switzerland). Samples were electrophoresed on sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) gels and then transferred to polyvinylidene difluoride membranes (Immobilon-P; Millipore Co., Burlington, MA, USA). The membranes were incubated with antiphosphorylated tyrosine mouse antibody (Cell Signaling Technology Inc., Danvers, MA, USA) overnight at 4°C, and then with horseradish peroxidase-conjugated anti-mouse IgG antibody (Cell Signaling Technology Inc.) for 1 h at room temperature. The blots were detected with Immunostar-D (Wako Pure Chemical Industries Ltd.) using an ImageQuant LAS-4000 (GE Healthcare Co., Wauwatosa, WI, USA).
Exploration of intracellular signalling molecules
NALM-6 cells were seeded into 96-well plates at 5 9 10 4 cells per well. After incubation for 24 h, acrofolione A or B (15 lM) was added and the cells were incubated for 24 and 48 h. The collected cells were rinsed with cold PBS and immediately solubilised in cell lysate buffer (Cell Signaling Technology) containing complete protease inhibitor cocktail (Roche Diagnostics Ltd.) and 1 mM phenylmethylsulfonyl fluoride (Sigma-Aldrich) by blocking the lysates gently at 4°C for 30 min. The supernatants obtained from microcentrifugation at 14000g for 5 min were transferred to clean test tubes, the sample proteins (0.5 mg/mL) were diluted and then incubated with PathScan Stress and Apoptosis Signaling Antibody Array kit reagent (Cell Signaling Technology) as per the manufacturer's instructions. [23] The expressed dots were visualised using LumiGlo reagent and detected using an ImageQuant LAS-4000. Dot densities were measured using Image J (National Institutes of Health, Bethesda, MD, USA) and corrected to the relative density of a-tubulin. Untreated cells served as the reference control. These measurements were performed independently three times.
Statistical analysis
Statistical analysis was performed by one-way analysis of variance with Tukey's and Dunnett's tests using SPSS version 22 (IBM, Armonk, NY, USA). Results are expressed as the mean AE standard deviation (SD). The level of statistical significance was set as P < 0.05.
Results and Discussion
Identification of acrofolione A and B
We isolated two compounds from the MeOH extraction of dried stems of A. pedunculate and identified them by highresolution electrospray ionisation mass spectrometry, IR . The purity of these compounds was estimated to be at least 98% based on the NMR spectra. The structures of the isolated compounds are shown in Figure 1 . All the spectral data of the isolated compounds were identical to the spectral data for acrofolione A (1) and B (2) reported by Oyama et al. [18] Cell growth inhibition effects
We investigated whether acrofolione A (1) and B (2) (Figure 1) inhibit the growth of three cell lines and have cytotoxic activity toward PBMNCs. Compound 2 dosedependently inhibited the proliferation of K562 and HPB-ALL cells (IC 50 18.2 AE 6.1 and 23.1 AE 2.3 lM, respectively). Compound 1 also dose-dependently suppressed the proliferation of these two cell lines and the NALM-6 cell line (IC 50 17.9 AE 0.3, 10.1 AE 0.2, and 16.7 AE 1.9 lM for K562, HPB-ALL, and NALM-6 cells, respectively). Neither compound affected the viability of PBMNCs because the cell viabilities of both compounds at 50 lM exceeded 50% ( Table 1 ). The IC 50 of acrofolione A (1) was higher than that of acrofolione B (2) in all tested cell lines (Table 1) , as in a previous report, [10] in which the IC 50 of compound 1 against human melanoma A2058 cells was 4.2 AE 0.6 lM and compound 2 had weakly cytotoxic effects. Although Oyama et al. [18] noted that the biological activities of the two compounds appear to differ depending on the cancer cell line, our results were consistent with other previous reports. [7, 10] As Epifano et al. [5] pointed out, previous studies reported only cytotoxic effects. 
Abnormal morphological changes in the nuclei of NALM-6 cells
The IC 50 of acrofolione A (1) against HPB-ALL cells was the lowest, although this activity was about twofold higher than that of acrofolione B (2). The difference in activity at 50 lM in NALM-6 cells was approximately fourfold (acrofolione A (1) 13.1% vs acrofolione B (2) 59.2%). With respect to the structure-activity relationship of these compounds for apoptosis, NALM-6 cells rather than HPB-ALL cells were expected to determine the difference in biological activities between 1 and 2. Thus, our subsequent experiments used NALM-6 cells. We first investigated the morphological changes in NALM-6 cells caused by each compound and found that both 1 and 2 induced abnormal changes in the nuclei, namely, nuclear retraction (Figure 2a) . In addition, both compounds time-dependently decreased the number of normal-looking cells, with 1 reducing the number of cells significantly more than 2 after 16h exposure (Figure 2b) . We then investigated whether acrofolione A (1) and B (2) induce the expression of TUNEL-positive (apoptotic) cells and found that at 24 h both compounds increased the percentage of TUNEL-positive cells more than fourfold compared with the control (Figure 2c and 2d) , suggesting that both 1 and 2 cause apoptosis. 
Apoptosis effects
We investigated whether the treatment of cells with acrofolione A (1) and B (2) induces annexin V binding to phosphatidylserine, and thus apoptosis. [24, 25] Both cells treated with compound 1 and those treated with 2 recognized annexin V-positive cells at all time points. We studied the subpopulation of annexin V-positive cells treated with each compound and found that the percent ratios of annexin V-positive propidium iodide-negative cells (early stage of apoptosis) of acrofolione A (1) and B (2) were approximately equal and gradually increased. The percent ratio of annexin V-positive propidium iodide-positive cells (late stage) for acrofolione A (1) increased over time and that for compound (1) at 48 h was about twofold higher than that of compound (2) (acrofolione A (1) 21.2% vs B (2) 9.7%, P = 0.00054) (Figure 3a) . Thus, the percent ratios of annexin V-positive cells after treatment with either 1 or 2 were nearly identical 24 h after treatment (Figure 3b ), whereas after 48 h, the ratio of annexin V-positive cells was about 1.5 times higher in cells treated with 1 compared with cells treated with 2. These kinetics results suggest that acrofolione A (1) and B (2) slowly induce apoptosis, supporting our observation of abnormal nuclei in NALM-6 cells treated with these compounds.
Next, NALM-6 cells were treated with 20 lM of either 1 or 2 for 48 h, and their mitochondrial membrane potentials were determined. The relative fluorescence intensities of the compound-treated cells shifted to the left as compared with non-treated cells, indicating a reduction in mitochondrial membrane potential (Figure 4a ). As shown in Figure 4b , the cell population with a downregulated mitochondrial membrane potential matched the population with a reduced cell size (representing area A), and this effect was most pronounced in 1-treated cells (Figure 4b) . Consequently, 1 and 2 induce apoptotic effects in NALM-6 cells, and the effect of acrofolione A (1) is higher than that of acrofolione B (2) .
Change in the cell cycle
In general, apoptosis is linked to the cell cycle either directly or indirectly via common cell signalling molecules, such as p53, Rb, and cyclin-dependent kinase. [26, 27] Quercetin and ellagic acid are components of natural products and induce G0/G1 arrest and apoptosis in HL-60 cells, CEM leukaemic human T-cells, and cervical carcinoma. [28] [29] [30] We therefore investigated whether the apoptotic effects of acrofolione A (1) and B (2) are linked to the cell cycle. The relative number of cells in the G0/ G1 phase, but not in the sub-G1 phase, of cells treated with either compound was higher than that of non-treated cells and increased moderately with time, whereas the relative values of cells in the S and G2/M phases decreased ( Figure 5 ). The cell viability of the nontreated cells was more than about 90% until 72 h (98.7% at 24 h, 98.2% at 48 h, and 93.1% at 72 h; trypan blue staining), and a time-dependent increase in cell proliferation was observed. The cell cycles of nontreated cells did not change during the culturing times ( Figure 5 ). Furthermore, the sub-G1 population of cells treated with 1 after 48 and 72 h was higher than in cells treated with 2, which agrees with the apoptosis experimental data. Recently, Srivastava et al. [31] reported that quercetin induces apoptosis via the mitochondrial pathway and causes S phase arrest during cell cycle progression in NALM-6 cells, whereas our findings showed that acrofolione A (1) and B (2) tended to arrest cells in the G0/G1 phase. Zhu et al. [32] reported that rottlerin-containing acetophenones induce G0/G1 arrest in adrenocortical carcinoma cell lines. Cho et al. [33] indicated that synthetic 3-geranyl-2,4,6-trihydroxyacetophenone, a phloroacetophenone derivative, affected the cell cycle, suggesting that acetophenone derivatives cause apoptosis in MCF-7 breast cancer cells. In future work, we will investigate the effect of our acetophenones on the cell cycle further because we could not confirm cell cycle arrest in the present study. 
Exploration of cell signalling molecules involved in apoptosis
Apoptosis is caused by various cell signalling molecules in both intrinsic and extrinsic pathways. We first focused on the activity of caspase 3/7, an apoptotic effector molecule. The luminescence of cells treated with 1 increased twofold, indicative of an increase in caspase 3/7 activity as compared with nontreated cells and cells treated with 2 at 24 h, demonstrating that 1 increased apoptosis faster than 2 did (Figure 6a ). To predict the target molecules of 1 and 2, docking simulations of these compounds and intracellular signalling molecules were performed using MOE (MOLSIS Inc., Tokyo, Japan). Scores for GBV/WSA dG (generalised Born volume integral/weighted surface area) binding free energy represent the likelihood of binding to a target compound and indicate that 1 has high scores for binding to SYK (À21.6), JAK3 (À21.5) or Abl kinase (À17.8), which are tyrosine kinases. [34] [35] [36] [37] Next, we explored apoptotic signalling molecules upstream and downstream of caspase 3/7 using the antiphosphorylated tyrosine antibody and an apoptosis protein array. The antiphosphorylated tyrosine antibody was recognized as four bands of about 15, 30, 50 and 70 kDa on SDS-PAGE in all cell lysates (Figure 6b) . The relative densities of 70-kDa bands from 1-or 2-treated cells for all defined incubation times were decreased in comparison with nontreated cells. Additionally, the relative density of the approximately 70-kDa band from 1-treated cells at 6 and 12 h was very low (Figure 6b ), whereas the relative density of the approximately 30-kDa band from 1-treated cells at 48 h was slightly increased compared with non-and 2-treated cells. Although the signalling molecules involved in apoptosis remain unclear, it seems likely that acrofolione A (1) partially regulates 30-and 70-kDa phosphorylated tyrosine proteins. We comprehensively analysed changes in signalling molecules using an apoptosis protein array. Compounds 1 and 2 at 24 h significantly increased the relative density of phosphorylated Chk2 and Bad, cleaved PARP, cleaved caspase 3 and cleaved caspase 7 protein levels compared with nontreated cells (Figure 7) and slightly decreased the relative density of survivin. At 48 h, the levels of cleaved PARP and cleaved caspase 7 in cells treated with either compound were higher than in the control, and the protein levels of phosphorylated HSP27, phosphorylated TAK1, total IjB and survivin were decreased. Cells treated with 1 showed moderately reduced phosphorylated Bad levels compared with cells treated with 2 at 48 h (Figure 7 ). Increases in cleaved caspase 3 and 7 protein levels by treatment with 1 but not with 2 were in good agreement with the activities of caspase 3 and 7. Survivin is a member of the inhibitor of apoptosis protein family, functions as a key regulator of mitosis and apoptosis, and is overexpressed in various cancer cells. [38, 39] This protein indirectly suppresses caspase 3 through regulation of X-chromosome-linked inhibitor of apoptosis protein (XIAP) and caspase 9. [38] Snabestari et al. [40] showed that CREB silencing in NALM-6 induced downregulation of XIAP and upregulation of cleaved PARP and caspase 3 and 7. Other reports have shown that XIAP regulates TAK-1, an upstream signalling molecule of p38 MAPK. [41, 42] The activation kinetics of other signalling molecules, such as phosphorylated Chk2 and phosphorylated HSP-27, may be involved in the G0/G1 arrest and intrinsic apoptosis pathway because Chk-2 and HSP-27 have multiple functions, such as in apoptosis and cell proliferation. [43] [44] [45] [46] Phosphorylated Bad is closely linked to cell survival [47, 48] but the relationship between levels of phosphorylated Bad and apoptosis remains unknown. Acrofolione A (1) and B (2) likely aid apoptosis rather than cell survival.
Conclusion
In conclusion, this study showed that acrofolione A (1) and B (2) have antiproliferative effects by causing apoptosis and G0/G1 arrest in NALM-6 cells. This apoptotic effect is closely associated with the reduction in survivin protein levels ( Figure 8 ). Acrofolione A (1) and B (2), isolated from A. pedunculata (L.) Miq. (Rutaceae), have potential as seed compounds for the development of therapeutic agents against acute leukaemia. The relationship between these compounds and individual signalling molecules will need to be clarified to identify target molecules.
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